Sponsor
Chong Kun Dang Pharmaceutical Corp.
8 Chungjeong-Ro, 03742
About the sponsor
Chong Kun Dang Pharmaceutical Corp. is active in clinical research for psoriatic arthritis, plaque psoriasis, and other immune-mediated inflammatory disorders. Its funded studies also reflect interest in conditions such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease.
- Psoriatic arthritis
- Moderate-to-severe plaque psoriasis
- Atopic dermatitis
- Asthma
- Chronic rhinosinusitis with nasal polyposis
The sponsor’s research portfolio includes immune-driven diseases affecting the skin, joints, airways, and gastrointestinal tract.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.